Vaccines for the New Millennium Act of 2005

3.0.0 3781 2023-01-13T04:50:12Z 2023-01-13T04:50:12Z House H HR 2005-09-14 109 hsba00 Financial Services Committee House Standing hsba19 Domestic Monetary Policy and Technology Subcommittee Referred to 2005-10-17T20:30:14Z Referred to 2005-09-15T02:46:55Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-10-07T20:10:58Z Referred to 2005-09-15T02:46:53Z hssm00 Small Business Committee House Standing Referred to 2005-09-15T02:46:54Z hsfa00 Foreign Affairs Committee House Standing Referred to 2005-09-15T02:46:52Z hswm00 Ways and Means Committee House Standing Referred to 2005-09-15T02:46:51Z Vaccines for the New Millennium Act of 2005 109 1698 S 2005-09-14 Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043) Identical bill CRS 2005-10-17 hsba19 Domestic Monetary Policy and Technology Subcommittee 1 House committee actions Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology. Committee 2005-10-07 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman. Committee 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsba00 Financial Services Committee 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hssm00 Small Business Committee 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsfa00 Foreign Affairs Committee 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-09-14 Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2005-09-14 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-09-14 Introduced in House IntroReferral 1000 9 Library of Congress V000108 Rep. Visclosky, Peter J. [D-IN-1] PETER VISCLOSKY D IN J. 1 N K000210 Rep. King, Peter T. [R-NY-3] PETER KING R NY T. 3 2005-09-20 False R000053 Rep. Rangel, Charles B. [D-NY-15] CHARLES RANGEL D NY B. 15 2005-10-07 False J000070 Rep. Jefferson, William J. [D-LA-2] WILLIAM JEFFERSON D LA J. 2 2005-10-07 False M000312 Rep. McGovern, James P. [D-MA-3] JAMES MCGOVERN D MA P. 3 2005-10-07 False P000149 Rep. Payne, Donald M. [D-NJ-10] DONALD PAYNE D NJ M. 10 2005-10-07 False D000096 Rep. Davis, Danny K. [D-IL-7] DANNY DAVIS D IL K. 7 2005-10-07 False M000590 Rep. McNulty, Michael R. [D-NY-21] MICHAEL MCNULTY D NY R. 21 2005-10-07 False L000551 Rep. Lee, Barbara [D-CA-9] BARBARA LEE D CA 9 2005-10-07 False S000344 Rep. Sherman, Brad [D-CA-27] BRAD SHERMAN D CA 27 2005-10-07 False M000404 Rep. McDermott, Jim [D-WA-7] JIM MCDERMOTT D WA 7 2005-11-02 False C000191 Rep. Carson, Julia [D-IN-7] JULIA CARSON D IN 7 2006-05-16 False W000314 Rep. Wexler, Robert [D-FL-19] ROBERT WEXLER D FL 19 2006-05-18 False B000574 Rep. Blumenauer, Earl [D-OR-3] EARL BLUMENAUER D OR 3 2006-05-23 False Health AIDS (Disease) Child health Clinical trials Commerce Communicable diseases Competition Congress Congressional reporting requirements Contracts Corporation taxes Developing countries Development credit institutions Dispute settlement Drug approvals Drug industry Drugs Economics and Public Finance Families Foreign Trade and International Finance Gifts Government Operations and Politics Government contractors Government procurement Government trust funds Governmental investigations Human immunodeficiency viruses Income tax Intellectual property International Affairs International agencies International cooperation in science Law Liability (Law) Malaria Medical malpractice Medical technology Negotiations Nongovernmental organizations Nonprofit organizations Patents Pharmaceutical research Preventive medicine Prices Public-private partnerships Research and development Research and development tax credit Research grants Science, Technology, Communications Small business Social Welfare Tax credits Tax refunds Taxation Technology transfer Treaties Tuberculosis United Nations Vaccination Vaccines World health Health

00 2005-09-14 Introduced in House 2005-11-08T20:07:18Z Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries.

Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.

Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.

Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.

]]>

Vaccines for the New Millennium Act of 2005 Display Title Vaccines for the New Millennium Act of 2005 Official Title as Introduced To accelerate efforts to develop vaccines for diseases primarily affecting developing countries, and for other purposes. Introduced in House IH Short Titles as Introduced Vaccines for the New Millennium Act of 2005 Introduced in House 2005-09-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr3781ih/xml/BILLS-109hr3781ih.xml 2005-10-17 Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.